According to Rauch and Kofler [13], the galanin peptide expression is studied in pheochromocytoma, pituitary adenoma, neuroblastic tumors, gastrointestinal cancer, squamous cell carcinoma, brain tumors, melanoma, breast cancer, and embryonal carcinoma. This evidence concerns the gene GAL and breast cancer.